Publications by authors named "Jun Ohsugi"

Article Synopsis
  • Cancer treatment with immune checkpoint inhibitors often lacks reliable predictive biomarkers, but the study suggests that the expressions of PD-L1 and tumor mutation burden (TMB) could be promising indicators.
  • The research evaluated 92 non-small-cell lung cancer patients through whole-exome sequencing to calculate TMB and analyzed cancer-related gene mutations along with PD-L1 expression and tumor-infiltrating lymphocytes.
  • The findings revealed that TMB was significantly higher in certain demographics (like men and smokers) and specific mutation statuses, with a suggestion that TMB could serve as an effective biomarker linked to EGFR and TP53 mutations for predicting treatment response.
View Article and Find Full Text PDF
Article Synopsis
  • Tumor mutation burden (TMB) may indicate the presence of neoantigens in tumors and help predict responses to immune checkpoint inhibitors, although its impact on prognosis, particularly in non-small cell lung cancer (NSCLC), remains unclear.* -
  • In a study of 90 NSCLC patients who had surgery without prior chemotherapy or immunotherapy, higher TMB levels were linked to significantly worse overall survival and disease-free survival rates.* -
  • The findings suggest that high TMB is a negative prognostic factor in NSCLC, indicating that using immune checkpoint inhibitors after surgery could potentially improve patient outcomes.*
View Article and Find Full Text PDF

We recently reported an increase in dicentric chromosome (DIC) formation after a single computed tomography (CT) scan (5.78-60.27 mSv: mean 24.

View Article and Find Full Text PDF

Excess risk of leukemia and brain tumors after CT scans in children has been reported. We performed dicentric chromosome assay (DCAs) before and after CT scan to assess effects of low-dose ionizing radiation on chromosomes. Peripheral blood (PB) lymphocytes were collected from 10 patients before and after a CT scan.

View Article and Find Full Text PDF

Thymic carcinoid is a rare disease that accounts for 3.1% of thymic tumors and 1.8-6% of all carcinoid tumors in Japan.

View Article and Find Full Text PDF

Purpose: Numerous biomarkers have been reported to reflect prognosis in patients with non-small cell lung cancer, but most of them remain controversial in terms of the clinical benefits. The aim of this study is to establish a novel procedure in combined analyses of molecular markers and biomedical image for precise prediction for patient prognosis of non-small cell lung cancer.

Experimental Design: Molecular markers related to cell cycle and proliferation and (18)F 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) were retrospectively analyzed for their utility as prognostic parameters in 54 patients with non-small cell lung cancer.

View Article and Find Full Text PDF

Despite of recent development in the field of molecular targeted therapies, lung cancer is a leading cause of cancer death in the world. Remarkable progress has been made recently in immunotherapy for patients with non-small-cell lung cancer (NSCLC), with several modalities, concepts, and treatment settings being investigated. In vaccine development, large-scale clinical trials such as those with L-BLP25, belagenpumatucel-L, TG4010, and talactoferrin are already ongoing and some results have been reported.

View Article and Find Full Text PDF

Hyponatremia is one of the major side effects that occurs after CDDP-based cancer chemotherapy. However, RSWS has rarely been reported as a cause of hyponatremia occurring after chemotherapy containing CDDP. A 70-year-old female who had recurrent lung adenocarcinoma after surgery was treated with CDDP, pemetrexed and bevacizumab-containing chemotherapy.

View Article and Find Full Text PDF

Carbohydrates antigens in cancer cells are considered to be important molecules, which may play a critical role for metastasis. To elucidate the prognostic relevance of the expression of peanut agglutinin (PNA) binding carbohydrates in patients with lung adenocarcinoma, we investigated the PNA binding carbohydrates immunohistochemically in both of primary tumors and involving nodal lesions. A total of 62 patients with node-positive primary lung adenocarcinoma, who had undergone complete resection and regional nodes dissection were subjected to this study.

View Article and Find Full Text PDF

A clinical significance of the aberrant expression of HLA class I molecules including HLA class I and HLA-G was analyzed using tissue array analysis. Our institute has established a two millimeter spot sized tissue array set of 105 clinical cases of resected human non small cell lung cancer tissues. A loss of HLA class I was observed in the 58.

View Article and Find Full Text PDF

Prognostic value of p53 protein expression in node-negative lung adenocarcinoma is still controversy. The expression of p53 protein was examined immunohistochemically in lung adenocarcinoma using monoclonal antibody BP53-12. A total 131 cases of primary lung adenocarcinoma were examined.

View Article and Find Full Text PDF

Objective: We evaluated preoperative pulmonary function as a predictor of respiratory complications and mortality in patients undergoing lung cancer resection to confirm the guideline of the British Thoracic Society: lung cancer surgery in patients with predictive postoperative FEV(1.0) (%FEV(1.0)ppo) > 40% and predictive postoperative diffusion capacity for carbon monoxide (%DL(co)ppo) > 40% can be carried out with average risk.

View Article and Find Full Text PDF